- €586.91m
- €921.08m
- €1.22bn
- 76
- 63
- 46
- 68
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,100 | 952 | 1,092 | 1,243 | 1,223 |
Cost of Revenue | |||||
Gross Profit | 630 | 537 | 612 | 664 | 668 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,003 | 932 | 1,000 | 1,166 | 1,147 |
Operating Profit | 96.7 | 20.1 | 92.1 | 76.5 | 76.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 81.2 | 5.38 | 79.7 | 63.9 | 53.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 58.4 | 5.48 | 56.1 | 39.2 | 27.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 58.4 | 5.67 | 55.9 | 39.1 | 27.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 58.4 | 5.67 | 55.9 | 39.1 | 27.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.13 | -0.208 | 1.38 | 0.861 | 0.605 |
Dividends per Share |